{"Pipobroman":{"RelatedTo":"DNA","Synonym":[", Amedel"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB00236","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB00236","Definition":"An antineoplastic agent that acts by alkylation. (PubChem) Pharmacology: Pipobroman is an antineoplastic agent. Specifically it is a piperazine derivative with a chemical structure close to that of many DNA alkylating agents. Pipobroman has well documented clinical activity against polycythemia vera and essential thrombocythemia. Mechanism of action: The mechanism of action is uncertain but pipobroman is thought to alkylate DNA leading to disruption of DNA synthesis and eventual cell death. Drug type: Approved. Small Molecule. Drug category: Antineoplastic Agents. Antineoplastic Agents, Alkylating"}}